Background
APL, Leukemia
ACUTE PROMYELOCYTIC LEUKEMIA, LEUKEMIA
Arsenic-based therapy substantially improves the prognosis of acute promyelocytic leukemia (APL). Besides arsenic trioxide (ATO), another arsenic compound, AsThe role of RIF in the treatment of children with APL remains less clear. To our knowledge, only one multicenter randomized trial has been published, which reported an interim analysis from our South China Children Leukemia Group (SCCLG) [